Discover
NDRA
ENDRA Life Sciences Inc.
5.04
2 x 3.80
2 x 6.78
bid
ask
-
0.29
5.44%
2 @ 04:00 PM
5.04 +0.00 (0.00%)
| Ytd | 11.26% | |
| 1y | 47.80% |
4.96
day range
5.40
2.96
52 week range
11.96
| Open | 5.30 | Prev Close | 5.33 | Low | 4.96 | High | 5.40 | Mkt Cap | 6.40M |
| Vol | 7.15K | Avg Vol | 28.16K | EPS | -8.16 | P/E | N/A | Forward P/E | -0.02 |
| Beta | 0.74 | Short Ratio | 0.05 | Inst. Own | 0.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-25 | 50-d Avg | 5.05 | 200-d Avg | 4.93 | 1yr Est | 2625.00 |
| Income Statement | |||
| Operating Expenses | 2.17M | ||
| Research and Development Expense | 776.41K | ||
| Selling, General and Administrative Expense | 1.40M | ||
| Operating Income | -2.17M | ||
| Net Income | -1.31M | ||
| Net Income Common Stock | -1.31M | ||
| Net Income Common Stock (USD) | -1.31M | ||
| Consolidated Income | -1.31M | ||
| Earnings per Basic Share | -1.09 | ||
| Earnings per Basic Share (USD) | -1.09 | ||
| Earnings per Diluted Share | -1.09 | ||
| Earning Before Interest & Taxes (EBIT) | -1.31M | ||
| Earning Before Interest & Taxes (USD) | -1.31M | ||
| Weighted Average Shares | 1.20M | ||
| Weighted Average Shares Diluted | 1.20M | ||
| Balance Sheet | |||
| Cash and Equivalents | 356.46K | ||
| Cash and Equivalents (USD) | 356.46K | ||
| Investments | 2.43M | ||
| Investments Non-Current | 2.43M | ||
| Current Assets | 536.67K | ||
| Property, Plant & Equipment Net | 464.75K | ||
| Total Assets | 3.44M | ||
| Debt Current | 133.95K | ||
| Total Debt | 949.81K | ||
| Current Liabilities | 835.44K | ||
| Debt Non-Current | 815.86K | ||
| Total Liabilities | 1.65M | ||
| Accumulated Retained Earnings (Deficit) | -111.78M | ||
| Shareholders Equity | 1.79M | ||
| Shareholders Equity (USD) | 1.79M | ||
| Assets Non-Current | 2.90M | ||
| Total Debt (USD) | 949.81K | ||
| Liabilities Non-Current | 815.86K | ||
| Trade and Non-Trade Payables | 701.49K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 39.72K | ||
| Net Cash Flow from Financing | 263.75K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -405.90K | ||
| Issuance (Purchase) of Equity Shares | 263.75K | ||
| Net Cash Flow from Investing | 450.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 450.00K | ||
| Net Cash Flow from Operations | -1.12M | ||
| Share Based Compensation | 574.45K | ||